, Google's parent company Alphabet has named longtime Eli Lilly CFO Anat Ashkenazi as the successor to its own outgoing CFO, Ruth Porat, who will be transitioning to a role as the company's chief investment officer.
The hiring of the pharmaceutical executive, who's overseen Eli Lilly's finances amid its massive growth from selling the weight loss drugs Mounjaro and Zepbound, comes during Google's own attempts at growth in the artificial intelligence field. "The AI era is giving us an incredible opportunity to innovate at scale across our core products," Alphabet CEO Sundar Pichai said of Ashkenazi's hiring, perAside from making two of the most popular glucagon-like peptide-1 agonists on the market, Eli Lilly has long been a pharmaceutical juggernaut for drugs like the erectile dysfunction medication Cialis and the antidepressant Prozac.
Indeed, in the wake of news of her hiring earlier in the week, Google's stock jumped and has been rising steadily since.
"We believe that Anat's experience as CFO of a biotech company will suit her well to steer in the age of AI," Thill told the financial outlet, "driving investments in new experimental AI products whose revenue may be uncertain and far off, while also protecting margins."